NEK2 and hepatocellular carcinoma: For instance, a study by Zhang et al. showed that NEK2 could promote the invasive ability of HCC cells by facilitating the epithelial–mesenchymal transition via several pathways including focal adhesion, VEGF, Hippo, and p53 pathways [32].